NL7608319A - Werkwijze ter bereiding van 1,2,3,4-tetrahydro- -isochinolinen, alsmede farmaceutische prepa- raten die deze verbindingen als actieve compo- nent bevatten. - Google Patents
Werkwijze ter bereiding van 1,2,3,4-tetrahydro- -isochinolinen, alsmede farmaceutische prepa- raten die deze verbindingen als actieve compo- nent bevatten.Info
- Publication number
- NL7608319A NL7608319A NL7608319A NL7608319A NL7608319A NL 7608319 A NL7608319 A NL 7608319A NL 7608319 A NL7608319 A NL 7608319A NL 7608319 A NL7608319 A NL 7608319A NL 7608319 A NL7608319 A NL 7608319A
- Authority
- NL
- Netherlands
- Prior art keywords
- tetrahydroisoqueinolins
- compounds
- preparation
- active component
- pharmaceutical preparations
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
- C07D257/06—Five-membered rings with nitrogen atoms directly attached to the ring carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
- C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
- C07D285/135—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB31570/75A GB1553230A (en) | 1975-07-28 | 1975-07-28 | 1 - aminomethyl - 6,7-dihydroxy - 1,2,3,4-tetrahydroisoquinolines and the preparation thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL7608319A true NL7608319A (nl) | 1977-02-01 |
Family
ID=10325102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL7608319A NL7608319A (nl) | 1975-07-28 | 1976-07-27 | Werkwijze ter bereiding van 1,2,3,4-tetrahydro- -isochinolinen, alsmede farmaceutische prepa- raten die deze verbindingen als actieve compo- nent bevatten. |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US4096263A (xx) |
| JP (1) | JPS5217477A (xx) |
| AR (1) | AR212174A1 (xx) |
| AT (1) | AT358588B (xx) |
| AU (1) | AU506715B2 (xx) |
| BE (1) | BE844472A (xx) |
| CA (1) | CA1068276A (xx) |
| CH (1) | CH623310A5 (xx) |
| DE (1) | DE2633692A1 (xx) |
| DK (1) | DK143750C (xx) |
| ES (1) | ES450206A1 (xx) |
| FR (1) | FR2319357A1 (xx) |
| GB (1) | GB1553230A (xx) |
| IE (1) | IE43502B1 (xx) |
| IT (1) | IT1063405B (xx) |
| MX (1) | MX3999E (xx) |
| NL (1) | NL7608319A (xx) |
| SE (1) | SE423233B (xx) |
| ZA (1) | ZA764508B (xx) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5734275B2 (xx) * | 1973-07-30 | 1982-07-22 | ||
| US4456757A (en) * | 1981-03-20 | 1984-06-26 | Asahi Kasei Kogyo Kabushiki Kaisha | Isoquinolinesulfonyl derivatives and process for the preparation thereof |
| GB8921304D0 (en) * | 1989-09-20 | 1989-11-08 | Wyeth John & Brother Ltd | New method of treatment and heterocyclic compounds used therein |
| JP4889463B2 (ja) * | 2006-12-07 | 2012-03-07 | 株式会社椿本バルクシステム | チェーンコンベヤ |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3389140A (en) * | 1966-05-16 | 1968-06-18 | Bristol Myers Co | 1-beta-arylaminoethyl-2-methyl-6, 7-dimethoxy-1, 2, 3, 4-tetrahydroisoquinolines |
| JPS5734275B2 (xx) * | 1973-07-30 | 1982-07-22 | ||
| US3963725A (en) * | 1973-07-20 | 1976-06-15 | Fujisawa Pharmaceutical Co., Ltd. | 1,2,3,4-Tetrahydroisoquinoline derivatives and the preparation thereof |
| US3994891A (en) * | 1974-12-20 | 1976-11-30 | Armour Pharmaceutical Company | Tetrahydroisoquinoline compounds |
-
1975
- 1975-07-28 GB GB31570/75A patent/GB1553230A/en not_active Expired
-
1976
- 1976-06-21 AR AR264017A patent/AR212174A1/es active
- 1976-07-21 US US05/707,271 patent/US4096263A/en not_active Expired - Lifetime
- 1976-07-23 BE BE169196A patent/BE844472A/xx not_active IP Right Cessation
- 1976-07-23 IT IT25672/76A patent/IT1063405B/it active
- 1976-07-26 SE SE7608453A patent/SE423233B/xx unknown
- 1976-07-26 DK DK336676A patent/DK143750C/da not_active IP Right Cessation
- 1976-07-27 IE IE1655/76A patent/IE43502B1/en unknown
- 1976-07-27 MX MX764843U patent/MX3999E/es unknown
- 1976-07-27 ES ES450206A patent/ES450206A1/es not_active Expired
- 1976-07-27 CA CA257,828A patent/CA1068276A/en not_active Expired
- 1976-07-27 NL NL7608319A patent/NL7608319A/xx not_active Application Discontinuation
- 1976-07-27 ZA ZA764508A patent/ZA764508B/xx unknown
- 1976-07-27 CH CH960976A patent/CH623310A5/de not_active IP Right Cessation
- 1976-07-27 AU AU16290/76A patent/AU506715B2/en not_active Expired
- 1976-07-27 FR FR7622896A patent/FR2319357A1/fr active Granted
- 1976-07-27 AT AT552076A patent/AT358588B/de not_active IP Right Cessation
- 1976-07-27 DE DE19762633692 patent/DE2633692A1/de not_active Withdrawn
- 1976-07-28 JP JP51090753A patent/JPS5217477A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ATA552076A (de) | 1980-02-15 |
| AU1629076A (en) | 1978-02-02 |
| MX3999E (es) | 1981-10-28 |
| JPS5217477A (en) | 1977-02-09 |
| DK336676A (da) | 1977-01-29 |
| IE43502B1 (en) | 1981-03-11 |
| AR212174A1 (es) | 1978-05-31 |
| GB1553230A (en) | 1979-09-26 |
| SE7608453L (sv) | 1977-01-29 |
| FR2319357B1 (xx) | 1978-11-17 |
| AU506715B2 (en) | 1980-01-24 |
| DE2633692A1 (de) | 1977-02-17 |
| DK143750B (da) | 1981-10-05 |
| SE423233B (sv) | 1982-04-26 |
| IE43502L (en) | 1977-01-28 |
| FR2319357A1 (fr) | 1977-02-25 |
| AT358588B (de) | 1980-09-25 |
| ES450206A1 (es) | 1977-11-16 |
| ZA764508B (en) | 1977-07-27 |
| DK143750C (da) | 1982-03-29 |
| IT1063405B (it) | 1985-02-11 |
| CA1068276A (en) | 1979-12-18 |
| US4096263A (en) | 1978-06-20 |
| CH623310A5 (xx) | 1981-05-29 |
| BE844472A (fr) | 1977-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL7714329A (nl) | Werkwijze ter bereiding van 3-de-0-methylforti- micinen alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten. | |
| NL7708741A (nl) | Werkwijze ter bereiding van prostaanzuurderiva- ten alsmede farmaceutische preparaten die deze derivaten als actieve component bevatten. | |
| NL7507268A (nl) | Werkwijze ter bereiding van 1(alpha),24-dihydroxy-chole- calciferolen, alsmede derivaten en voorlopers daar- van , alsmede farmaceutische preparaten die deze ver- bindingen als actieve componenten bevatten. | |
| NL7702548A (nl) | Werkwijze ter bereiding van 3,7-digesubstitueerde- -3-cefem-4-carbonzuurverbindingen, alsmede farma- ceutische preparaten die deze verbindingen als actieve component bevatten. | |
| NL7603193A (nl) | Werkwijze ter bereiding van acyclische, alicycli- sche en aromatische n-gesubstitueerde halogeen-2- -pyrrolidinonen met herbicidewerking alsmede her- bicidepreparaten die deze verbindingen als actie- ve component bevatten. | |
| NL7700379A (nl) | Werkwijze ter bereiding van anthracyclinegly- cosiden, alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten. | |
| NL7614538A (nl) | Werkwijze ter bereiding van farmacologisch actieve heterocyclische verbindingen en farmaceutische preparaten die deze verbindingen bevatten. | |
| NL7706064A (nl) | Werkwijze ter bereiding van heterocyclische verbindingen alsmede van farmaceutische pre- paraten die deze verbindingen als actieve component omvatten. | |
| NL7713470A (nl) | Werkwijze ter bereiding van 2-gesubstitueerde benzimidazoolverbindingen en de zuuradditiezou- ten daarvan alsmede farmaceutische preparaten die deze verbindingen als actieve component be- vatten. | |
| NL7610480A (nl) | Werkwijze ter bereiding van hypolipemische ver- bindingen alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten. | |
| NL7607337A (nl) | Werkwijze ter bereiding van spirocycloalkyl- prostaanzuren en derivaten daarvan, alsmede geneeskundige preparaten die deze verbindingen als actieve component bevatten. | |
| NL7604797A (nl) | Werkwijze ter bereiding van nieuwe antibacteriele middelen alsmede preparaten die deze verbindingen als actieve component bevatten. | |
| NL7609559A (nl) | Werkwijze ter bereiding van oxazolidinonen alsmede geneeskrachtige middelen die deze ver- bindingen als actieve component bevatten. | |
| NL7711414A (nl) | Werkwijze ter bereiding van n-gesubstitueerde lactamen, alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten. | |
| NL7708982A (nl) | Werkwijze ter bereiding van dihydro-oxo-nicotine- zuren, alsmede farmaceutische preparaten die de- ze verbinding als actieve component bevatten. | |
| NL7607975A (nl) | Werkwijze ter bereiding van difenylsulfiden alsmede farmaceutische preparaten die deze verbindingen als actieve component omvatten. | |
| NL7702180A (nl) | Werkwijze ter bereiding van 9-gesubstitueerde- -8-azapurinen alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten. | |
| NL7707150A (nl) | Werkwijze ter bereiding van 2-lagere alkyl-7-ge- substitueerde-2 of 3-cefem-4-carbonzuurverbin- dingen, alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten. | |
| NL7508740A (nl) | Werkwijze voor de bereiding van de amiden van apo- vincaminezuur en van desoxyvincaminezuur alsmede werkwijze voor de bereiding van preparaten, die deze verbindingen bevatten. | |
| NL7412302A (nl) | Werkwijze ter bereiding van pyrazoliumverbindin- gen, alsmede herbicide preparaten die deze ver- bindingen als actieve component bevatten. | |
| NL7613041A (nl) | Werkwijze ter bereiding van picolinezuurderiva- ten alsmede preparaten die deze verbindingen als actieve component omvatten. | |
| NL7714063A (nl) | Werkwijze ter bereiding van imidazolinen alsmede pesticidepreparaten die deze verbindingen als actieve component bevatten. | |
| NL7613334A (nl) | Werkwijze ter bereiding van carbamaat-sulfenyl- -carbamoylfluorideverbindingen, alsmede pestici- de preparaten die deze verbindingen als actieve component omvatten. | |
| NL7608319A (nl) | Werkwijze ter bereiding van 1,2,3,4-tetrahydro- -isochinolinen, alsmede farmaceutische prepa- raten die deze verbindingen als actieve compo- nent bevatten. | |
| NL7607494A (nl) | Werkwijze ter bereiding van 2-benzopyranonderi- vaten alsmede geneeskundige preparaten die deze verbindingen als actieve component bevatten. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BA | A request for search or an international-type search has been filed | ||
| BB | A search report has been drawn up | ||
| BC | A request for examination has been filed | ||
| A85 | Still pending on 85-01-01 | ||
| BV | The patent application has lapsed |